Norgine Sverige AB is a pharmaceutical company based in Stockholm, Sweden. It operates as a subsidiary of Norgine B.V., which is an international pharmaceutical company headquartered in the Netherlands. Norgine specializes in the development and commercialization of products for various therapeutic areas, including gastroenterology, pain management, and critical care.
The company focuses on providing innovative solutions to improve patient outcomes and enhance the quality of healthcare. Norgine Sverige AB is involved in both the development of new pharmaceutical products and the distribution of existing medications within the Swedish market. Its commitment to research and development plays a crucial role in its operations, as the company seeks to address unmet medical needs through its product offerings.
Norgine Sverige AB adheres to regulatory standards and guidelines in the pharmaceutical industry, ensuring that its products meet safety and efficacy requirements. The company collaborates with healthcare professionals and organizations to support the effective use of its products and to contribute to advancements in medical treatment.
